An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...

FDA alignment on a single-dose Phase 3 study design and potential single-trial registration pathway further strengthens the Company's clinical ...

Women with cancer may not have the same chance of cure or quality of life as men—yet fewer than 2% of Australian cancer ...

TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell ...

Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced the completion of a ...

ATAI completes dosing in the phase IIb Elumina study of VLS-01 for treatment-resistant depression, with top-line efficacy and ...

An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a ...

Securing central venous access in neonates and infants is one of the most technically demanding tasks in pediatric anesthesia ...

The transmission of optical information through random scattering media is a major challenge in optics, biomedical imaging, ...

Explore why men grow beards beyond fashion trends. Discover the psychological impacts of facial hair on perceptions of age, ...

RNA design is central to next-generation therapeutics, yet identifying sequences that reliably fold into desired structures ...

Obstetrics and gynecology increasingly intersect with traditional, homeopathic, and alternative medicine as patients seek complementary options across the ...